The Effect of a Diabetic- and a Kidney-like Environment on Gene and Protein Expression in Cultured EC and SMC
NCT01423279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-09-01
Summary
This research is NOT part of an interventional trial, however the investigators use umbilical cord after birth for isolating endothelial and smooth muscle cells for academic research.
Conditions
- Endothelial Dysfunction
- Disorder of Smooth Muscle
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Principal Investigators
-
Sydney Benchetrit, MD · Nephrology dept. Meir Medical Center, Kfar Saba , Israel
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2022-08-31
- Completion
- 2022-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Development of a Multidisciplinary Network for Clinical and Laboratory Research for SMA
NCT05866939 ·Status: UNKNOWN
-
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
NCT02109692 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
NCT01610440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
NCT02895789 ·Status: COMPLETED
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy
NCT02285673 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
NCT07172971 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
NCT02587572 ·Status: WITHDRAWN ·Phase: PHASE2
-
Measuring Levels of SMN in Blood Samples of SMA Patients
NCT00061607 ·Status: COMPLETED
-
Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)
NCT06280482 ·Status: RECRUITING ·Phase: PHASE1
-
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
NCT02235844 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E
NCT06218134 ·Status: COMPLETED ·Phase: NA
-
Metabolomics of Children With SMA
NCT04587492 ·Status: COMPLETED
-
Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
NCT04385056 ·Status: UNKNOWN ·Phase: PHASE1
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
NCT02196467 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy
NCT01851447 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
Evaluation of Limb-Girdle Muscular Dystrophy
NCT00893334 ·Status: COMPLETED
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
NCT00244582 ·Status: COMPLETED
-
Gentamicin Treatment of Muscular Dystrophy
NCT00005574 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104 ·Status: RECRUITING
-
A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19.
NCT05787288 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NCT02516085 ·Status: COMPLETED ·Phase: PHASE1